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Abstract
Background: The microtubule-associated protein tau is able to interact with actin and serves as
a cross-linker between the microtubule and actin networks. The microtubule-binding domain of
tau is known to be involved in its interaction with actin. Here, we address the question of whether
the other domains of tau also interact with actin.
Results: Several tau truncation and deletion mutants were constructed, namely N-terminal region
(tauN), proline-rich domain (tauPRD), microtubule binding domain (tauMTBD) and C-terminal
region (tauC) truncation mutants, and microtubule binding domain (tauΔMTBD) and proline-rich
domain/microtubule binding domain (tauΔPRD&MTBD) deletion mutants. The proline-rich domain
truncation mutant (tauPRD) and the microtubule binding domain deletion mutant (tauΔMTBD)
promoted the formation of actin filaments. However, actin assembly was not observed in the
presence of the N-terminal and C-terminal truncation mutants. These results indicate that the
proline-rich domain is involved in the association of tau with G-actin. Furthermore, results from
co-sedimentation, solid phase assays and electron microscopy showed that the proline-rich domain
is also capable of binding to F-actin and inducing F-actin bundles. Using solid phase assays to analyze
apparent dissociation constants for the binding of tau and its mutants to F-actin resulted in a
sequence of affinity for F-actin: tau >> microtubule binding domain > proline-rich domain.
Moreover, we observed that the proline-rich domain was able to associate with and bundle F-actin
at physiological ionic strength.
Conclusion: The proline-rich domain is a functional structure playing a role in the association of
tau with actin. This suggests that the proline-rich domain and the microtubule-binding domain of
tau are both involved in binding to and bundling F-actin.
Background
Tau is an important microtubule-associated protein, pro-
moting microtubule assembly and stabilizing microtu-
bules [1-3]. The protein is recognized as a multifunctional
molecule that interacts with actin in addition to microtu-
bules [4-12], and is involved in the organization of the
cytoskeletal network [4,5]. Actin monomers (G-actin)
were found to form gels in the presence of tau [8]. Accord-
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ing to Farias and colleagues [5], the association of tau with
tubulin immobilized on a solid phase support system is
inhibited by actin monomers, and a higher inhibition can
be attained with preassembled actin filaments. Interest-
ingly, tau can interact with F-actin, resulting in bundles of
F-actin. MacLean-Fletcher and Pollard [6] have observed
that tau dramatically induces an increase in the viscosity
of actin filaments. Using electron microscopy tau has
been shown to be capable of bundling microfilaments.
Examination of morphological aspects of microtubules
and actin filaments which coexist in vitro revealed associ-
ations between both cytoskeletal filaments, and in some
cases, the presence of fine filamentous structures bridging
these polymers [7]. Several reports have demonstrated
that tau interacts with actin in vivo. Sub-portions of tau co-
immunoprecipitated with actin filaments have been
found in various cell types [4]. As described by Yu and col-
leagues [13], under NGF stimulation, tau is distributed at
the ends of cellular extensions, where it associates with
actin in a microtubule-independent manner in PC12 cells.
Moreover, Fluga and co-workers [14] have provided evi-
dence that tau induces changes in the organization and
stability of neuronal actin filaments, which in turn con-
tributes to Alzheimer's-like neurodegeneration in Dro-
sophila  and mouse model systems. This further
demonstrates the physiological importance of interac-
tions between tau and actin.
According to Buee and colleagues [15], tau consists of four
parts: the N-terminal region, the proline-rich domain
(PRD), the microtubule-binding domain (MTBD) and the
C-terminal region. The microtubule binding domain has
been reported to bind to actin [7,9], but no data is availa-
ble for the other regions bound to actin. It has been pro-
posed that the proline-rich domain of tau participates in
interactions with microtubules [16-18]. Interactions
between tau and DNA have been studied in our laboratory
[19], and PRD and MTBD were found to associate cooper-
atively with the minor groove in DNA double strands.
These results intrigued and led us to investigate whether
the proline-rich domain of tau also participates in interac-
tions with actin.
Results
Tau binds to G-actin and F-actin from skeletal muscle and 
platelets
Human actin has three subtypes, alpha actin being found
primarily in muscle, and beta and gamma actin in other
tissues. The interaction of tau with alpha actin has been
well studied, however, little attention has been given to
beta and gamma actin. Since tau mainly exists in neurons,
beta and gamma actin are the subtypes of actin that tau
can encounter. In this work we mainly used skeletal mus-
cle actin. Platelet actin (a mixture of beta and gamma
actin) was also employed to test whether subtypes of actin
differ in their interactions with tau.
Here, solid phase assays were used to study interactions
between tau and actin. Human tau23 (352 aa) was
employed in our experiments. G-actin and F-actin from
skeletal muscle and platelets were immobilized in 96-well
plates, and increasing concentrations of tau were added.
Levels of bound tau were monitored by using an anti-tau
monoclonal antibody. As illustrated in Figure 1, absorb-
ance increased with increasing tau concentration, indicat-
ing a positive correlation between added tau and bound
tau. BSA used as a negative control showed no interaction
with G-actin or F-actin (data not shown). These results
suggest that tau is capable of binding to G-actin and F-
actin.
As shown in Table 1, the data could be fitted to a one-site
binding model. Kapp and Bmax values for the binding of
G-actin and F-actin to tau showed close agreement, sug-
gesting that polymerization of G-actin does not affect its
binding to tau. Similar patterns were observed for the
binding of tau to G-actin and F-actin from both skeletal
muscle and platelets.
The proline-rich domain is involved in binding to G-actin
Co-sedimentation assays are commonly used to investi-
gate the binding of specific proteins or protein domains
with actin [8]. Low speed centrifugation (25,000 g) can
only pellet F-actin bundles, while high speed centrifuga-
tion (100,000 g) can pellet all F-actin filaments. Under
our experimental conditions, tau could co-sediment with
Binding of tau to actin detected by solid phase assay Figure 1
Binding of tau to actin detected by solid phase assay. 
Wells were coated with 50 μl G-actin and F-actin (5 μg/ml) 
from skeletal muscle and platelets, respectively. Aliquots of 
different concentrations of tau (from 0.03 to 0.55 μM) were 
incubated with actin in binding buffer (50 mM Hepes contain-
ing 0.5 mM EGTA and 0.5 mM MgCl2, pH 7.5). Immunoreac-
tivity was monitored in the solid phase assay using secondary 
antibody-labelled HRP. Each point represents the mean of 
five determinations.BMC Cell Biology 2009, 10:81 http://www.biomedcentral.com/1471-2121/10/81
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actin by low speed centrifugation (Figure 2; panel a, Fig-
ure 3). This result indicated that tau can both induce
polymerization of G-actin to F-actin and to F-actin bun-
dles. To investigate the roles of the four regions of tau in
interactions with actin, we designed a group of primers
(Additional file 1) and constructed a series of tau trunca-
tion and deletion mutants: mutants in which the N-termi-
nal region (tauN), proline-rich domain (tauPRD),
microtubule-binding domain (tauMTBD), C-terminal
region (tauC) were separated, and mutants in which the
MTBD (tauΔMTBD), and both the MTBD and PRD
domains (tauΔPRD&MTBD) were deleted (Figure 4).
Results indicated that the deletion of MTBD did not elim-
inate the ability of tau to bind to actin since both ΔMTBD
and G-actin were present in protein pellets as shown by
SDS-PAGE (panel a, Figure 2). Under our experimental
conditions, the tauN, tauC and tauΔPRD&MTBD (panel
b, Figure 3) mutants exhibited no association with actin in
co-sedimentation assays, indicating that the proline-rich
domain may be an essential domain involved in the asso-
ciation of tau with actin. Incubation of the tauPRD
mutant with G-actin gave rise to a positive result in co-sed-
imentation assays, and tauPRD, tauMTBD, tau and BSA
alone used as negative controls did not show any deposits
in co-sedimentation assays (Additional file 2). To judge
the efficiency of bundling during the reaction, both the
pellet and supernatant fraction were loaded in gels (panel
a, Figure 3). The result showed that most of the G-actin
was in the pellet fraction under the experimental condi-
tions, presenting the formation of F-actin bundles. Taken
together, these results suggest that the proline-rich
domain is involved in the association of tau with G-actin.
Platelet actin was also used in low speed co-sedimentation
assays. Results were similar to those obtained for skeletal
Table 1: Biochemical Binding Parameters from Solid Phase 
Assays
actin Bmax (μM) Kapp (μM) R
α-G- 2.10 ± 0.07 0.031 ± 0.007 0.99
α-F- 2.31 ± 0.05 0.030 ± 0.004 0.99
β/γ-G- 1.90 ± 0.06 0.029 ± 0.005 0.99
β/γ-F- 2.01 ± 0.04 0.027 ± 0.003 0.99
Conditions were the same as those referred to in Figure 1. Binding 
parameters were estimated with the non-linear curve fit Hyperbl 
function (ΔA450 = Bmax * [tau]/(Kapp+ [tau]) in the Origin program.
Low speed co-sedimentation assay of G-actin in the presence  of tau and tau mutants Figure 2
Low speed co-sedimentation assay of G-actin in the 
presence of tau and tau mutants. Tau and tau mutants 
were incubated with G-actin in a 1:1 mass ratio at 37°C in 
binding buffer and then centrifuged (25,000 g, 4°C, 30 min). 
Before electrophoresis on gels, pellets were resuspended 
with 20 mM Tris-HCl (pH 8.0) and boiled for 5 min. Rabbit 
skeletal muscle G-actin (panel a) and human platelet G-actin 
(panel b) were used. Actin alone was used as negative con-
trol. Different concentrations of tauΔPRD&MTBD reacted 
with G-actin. The pellets were electrophoresed on 12% SDS-
PAGE gels after the centrifugation (panel c).
G-actin in the presence of tau mutants at low speed co-sedi- mentation assay Figure 3
G-actin in the presence of tau mutants at low speed 
co-sedimentation assay. Conditions were referred to Fig-
ure 2, G-actin (4 μg) was incubated with equal amount of 
tauRPD, tauMTBD, tau (panel a), and with tauΔPRD&MTBD 
(panel b) in binding buffer for 20 min in 37°C, followed by 
low-speed centrifugation. The pellet fraction (P) and superna-
tant fraction (S) were loaded in gels.BMC Cell Biology 2009, 10:81 http://www.biomedcentral.com/1471-2121/10/81
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muscle actin (panel b, Figure 2). Under the same condi-
tions, tauPRD bound to skeletal muscle and platelet actin
without discrimination, i.e. tauPRD was capable of bind-
ing to alpha-, beta- and gamma-actin. These results again
indicate that in addition to the microtubule-binding
domain, the proline-rich domain played an important
role in the association of tau with actin.
Atomic force microscopy was used to observe the mor-
phology of actin-tauPRD complexes (Figure 5). Filaments
were observed after globular platelet actin was incubated
with tauPRD. Under the experimental conditions used,
tau, tauΔMTBD and tauMTBD also induced formation of
F-actin. When tauN, tauC and BSA were incubated sepa-
rately with G-actin, no filaments were observed (data not
shown). G-actin and tau were observed as globular parti-
cles in the absence of actin. This demonstrates again that
tauPRD is a functional domain involved in the associa-
tion of tau with actin and in the promotion of G-actin
assembly.
The proline-rich domain binds to F-actin and promotes F-
actin bundling
That tauPRD co-sedimented with actin under low-speed
centrifugation suggested the formation of F-actin bundles.
To investigate the induction of F-actin bundles, alpha F-
actin was incubated with different concentrations of tau-
PRD, followed by high speed centrifugation to pellet the
F-actin-bound tauPRD (panel a, Figure 6). TauPRD alone
and tau with F-actin were used as a negative and positive
control, respectively (panel b and c, Figure 6). As shown
in Figure 6, tauPRD co-sedimented with F-actin, showing
that tauPRD binds to F-actin, although its affinity with F-
actin was weaker than that of tau.
To confirm the results from co-sedimentation assays, the
association of tauPRD, tauMTBD or tau with F-actin was
also analyzed by solid phase assay. As shown in Figure 7,
tauPRD, tauMTBD and tau could bind to F-actin. Kapp
and Bmax values were analyzed as previously (Table 2).
The value of Kapp for tauPRD was greater than that for
tauMTBD and at least 10 times greater than that for tau
(KapptauPRD: KapptauMTBD: Kapptau ≈ 19:10:1) (Table 2).
The value of BmaxtauPRD was close to that of BmaxtauMTBD,
but less than that of Bmaxtau. Bmaxtau was approximately
equal to the sum of BmaxtauPRD and BmaxtauMTBD, suggest-
ing that both the PRD and MTBD domains of tau bind to
F-actin simultaneously.
Low-speed co-sedimentation was used to measure F-actin
bundles in the presence of tauPRD. As shown in Figure 8,
tauPRD co-sedimented with F-actin, clearly showing that
bundles were formed during the reaction. Similar results
were observed when tau and tauMTBD were used as posi-
tive controls.
Construction of tau and its mutants Figure 4
Construction of tau and its mutants. Six truncated tau 
isolation and deletion mutants were constructed: tauN (N-
terminal region, 1-113), tauPRD (proline-rich domain, 114-
193, containing 22 proline residues), tauMTBD (microtubule-
binding domain, 198-278) and tauC (C-terminal region, 279-
352). TauΔMTBD is a mutant in which the MTBD domain is 
deleted. TauΔPRD&MTBD is a mutant in which both PRD 
and MTBD are deleted.
Interactions of tauPRD with G-actin observed by atomic  force microscopy Figure 5
Interactions of tauPRD with G-actin observed by 
atomic force microscopy. Skeletal muscle (M) and platelet 
(P) G-actin were incubated with tauPRD in binding buffer at 
37°C for 30 min and then aliquots were taken for observa-
tion by atomic force microscopy as indicated. Bars in panels 
are 50 nm.BMC Cell Biology 2009, 10:81 http://www.biomedcentral.com/1471-2121/10/81
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Electron microscopy was used to clarify whether tauPRD
is able to induce F-actin bundles. Significantly, tauPRD
was found to be bound to skeletal muscle F-actin, leading
to bundle formation (diameter 38.53 ± 12.32 nm, n = 30)
as shown in Figure 9. TauMTBD was used as a positive
control. Incubation of tauMTBD with F-actin resulted in
bundles (diameter 28.80 ± 8.43 nm, n = 30) but a few fil-
aments remained (diameter 8.61 ± 1.29, n = 30). Tau
induced bundling of muscle and platelet F-actin (diame-
ter 54.84 ± 31.84 nm, n = 30). A few actin filaments were
observed in the presence of tauPRD or tau. In the absence
of tau and the mutants, however, F-actin from muscle tis-
sue or platelets did not form bundles and remained as fil-
aments (diameter 8.58 ± 2.21 nm, n = 30).
TauPRD induces F-actin bundles at physiological ionic 
strength
To clarify whether tau interacts with actin in the presence
of salts under physiological conditions, we added differ-
ent concentrations of NaCl to the reaction buffer. After
incubating F-actin with tau, low speed co-sedimentation
assays showed that the amount of F-actin and tau in the
pellets decreased as the concentration of NaCl increased
(Figure 10). Similar results were obtained when tauMTBD
or tauPRD were employed instead of tau. Under the exper-
imental conditions used, F-actin alone, or with BSA,
showed no significant protein precipitates (Additional file
2-b, c). Likewise, precipitates were not detected when tau-
High speed co-sedimentation assay of tauPRD and F-actin Figure 6
High speed co-sedimentation assay of tauPRD and F-
actin. F-actin (at a constant concentration) was incubated 
with different concentrations of tauPRD (panel a), tauPRD 
alone (panel b) and tau (panel c) in the binding buffer without 
addition of extra NaCl at 37°C for 40 min and then centri-
fuged (100,000 g, 4°C, 60 min). The pellet and supernatant 
were electrophoresed on 12% SDS-PAGE gels.
Table 2: Biochemical Binding Parameters from Solid Phase 
Assays
Tau Bmax (μM) Kapp (μM) R
tau 2.31 ± 0.05 0.03 ± 0.004 0.99
tauPRD 0.81 ± 0.05 0.57 ± 0.09 0.99
tauMTBD 1.09 ± 0.01 0.29 ± 0.01 0.99
Data were taken from Figure 6, and conditions were the same as for 
Table 1, except that the reaction of F-actin with tauPRD was 
monitored by solid phase assay.
Solid phase assay studies on the interaction of tauPRD with  F-actin Figure 7
Solid phase assay studies on the interaction of tau-
PRD with F-actin. 50 μl skeletal muscle F-actin (5 μg/ml) 
was added to solid phase assay wells. Aliquots of different 
concentrations of tauPRD (❍), tau () and tauMTBD () 
were incubated with actin in binding buffer. Immunoreactivity 
was monitored using secondary antibody-labelled HRP. Each 
point represents the mean of five determinations. Binding 
parameters were estimated by fitting data using the Hyperbl 
function in Origin (Table 2).BMC Cell Biology 2009, 10:81 http://www.biomedcentral.com/1471-2121/10/81
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PRD, tauMTBD, tau or BSA were used in the absence of
actin as controls.
It is well known that low-speed centrifugation (25,000 g)
can precipitate actin bundles but not actin filaments. A
few bundles associated with tau could be observed at
physiological ionic strength (150 mM NaCl) as shown in
Figure 10. We used high-speed centrifugation to further
investigate the interaction between tauPRD and F-actin at
physiological strength. As shown in Figure 11 (panel a),
tauPRD still co-sedimented with actin in the presence of
150 mM NaCl. Under the same conditions, association of
tau with F-actin was also visualized (panel b, Figure 11).
Electron microscopy was employed to examine the mor-
phological details of interactions between F-actin and tau
or its mutants in the presence of different concentrations
of NaCl. As shown in Figure 12, bundles of F-actin could
still be observed in 150 mM or higher concentrations of
NaCl. The diameter of the actin bundles (39.00 ± 5.86
nm) was similar to those present in the absence of NaCl
(38.60 ± 7.28 nm). When NaCl concentration was
increased to 300 mM, bundles and some filaments were
observed to co-exist in the same visual field. As shown in
Additional file 3, the diameter of the bundles was 30.97 ±
8.43 nm and that of the filaments was 8.33 ± 1.29 nm,
similar to those present in the absence of NaCl (8.40 ±
1.65 nm). Even when the salt concentration was as high
as 500 mM, bundles of F-actin (30.46 ± 6.30 nm diame-
ter) could still be seen in the presence of tauPRD. That is
to say that tauPRD was able to promote the assembly of F-
actin into bundles at high concentrations of NaCl, but
that the diameter of these bundles was somewhat lower
than that of those formed in the absence of NaCl. Under
our experimental conditions, similar results were
obtained for tau and tauMTBD, as indicated in Figure 12.
F-actin alone as a control did not assemble in the presence
or absence of NaCl but existed in filaments of similar
diameter (8.40 ± 1.65 nm ~9.95 ± 2.09 nm) (Additional
file 3). On the other hand, some actin globules were
observed when the NaCl concentration was increased to
Low speed co-sedimentation assay of F-actin in the presence  of tauPRD Figure 8
Low speed co-sedimentation assay of F-actin in the 
presence of tauPRD. Conditions were the same as those 
described for Figure 4, except that F-actin (5 μg) from skele-
tal muscle (used in panels a, b and c) and platelet actin (used 
in panel d) were incubated with tau at concentrations of 0, 1, 
3, 5, 7, 10, and 15 μM (lanes 3 to 9 in each panel) and with 
tauPRD or tauMTBD at concentrations of 0, 5, 10, 15, 25, 35, 
and 45 μM (lanes 3 to 9). After sedimentation at 25,000 g, 
pellets of bundles were electrophoresed on SDS-PAGE gels. 
Total amount of F-actin (lane 1) and BSA alone (lane 2) were 
used as controls.
Electron microscope images of F-actin incubated with tau- PRD Figure 9
Electron microscope images of F-actin incubated 
with tauPRD. F-actin was incubated with tauPRD, 
tauMTBD and tau23 as described in Figure 4 and visualized 
with electron microscope. F-actin alone was shown as nega-
tive control. Bars in panels are 100 nm.BMC Cell Biology 2009, 10:81 http://www.biomedcentral.com/1471-2121/10/81
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500 mM, suggesting that actin filaments started to col-
lapse at these high salt concentrations. Tau, tauPRD or
tauMTBD appeared as particles without any filaments or
bundles in the absence of actin under these experimental
conditions (Additional file 4).
Discussion
Studies on the interaction of tau with actin have generally
focussed on the relationship between MTBD and alpha-
actin [7,9]. Here we show that the proline-rich domain of
tau is also capable of binding to actin, promoting G-actin
assembly and F-actin bundling. Our results indicate that:
(1) tau is still able to interact with actin after the microtu-
bule binding domain has been deleted (mutant tauΔ
MTBD); (2) the isolated proline-rich domain alone was
able to associate with actin; (3) the tauN, tauC truncation
mutants, and the ΔPBD&MTBD deletion mutant showed
no interaction with actin; and (4) the isolated proline-rich
domain was still able to induce F-actin bundling.
Compared to the microtubule binding domain, the pro-
line-rich domain of tau is a relatively less-well character-
ized domain. However, evidence has shown that this
domain is functionally important and participates in mul-
tiple biological processes. PRD has been demonstrated to
Low speed Co-sedimentation assays of tauPRD in the pres- ence of F-actin in the presence of NaCl Figure 10
Low speed Co-sedimentation assays of tauPRD in the 
presence of F-actin in the presence of NaCl. Condi-
tions were the same as those in Figure 4, except that F-actin 
was used instead of G-actin. F-actin was incubated with tau-
PRD, tau or tauMTBD at different concentrations of NaCl, 
and precipitates were electrophoresed on SDS-PAGE gels as 
indicated.
High speed co-sedimentation assays of tauPRD and F-actin in  the presence of NaCl Figure 11
High speed co-sedimentation assays of tauPRD and 
F-actin in the presence of NaCl. F-actin (at a constant 
amount) was incubated with different amounts of tauPRD 
(panel a) and tau (panel b) in binding buffer with 150 mM 
NaCl at 37°C for 40 min to mimic physiological ionic 
strength and then centrifuged (100,000 g, 4°C, 60 min). The 
pellet and supernatant were electrophoresed on 12% SDS-
PAGE gels.BMC Cell Biology 2009, 10:81 http://www.biomedcentral.com/1471-2121/10/81
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Electron microscopy images of F-actin incubated with tauPRD in the presence of NaCl at different concentrations Figure 12
Electron microscopy images of F-actin incubated with tauPRD in the presence of NaCl at different concentra-
tions. Conditions were the same as those in Figure 7, except that different concentrations of NaCl were added to the reaction 
mixtures of F-actin and tauPRD (tau or tauMTBD) as indicated. The bar in each panel represents 200 nm.BMC Cell Biology 2009, 10:81 http://www.biomedcentral.com/1471-2121/10/81
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be an indispensable domain for tau's stabilization of
microtubules [20,21]. Further work has shown that PRD
may interact with the N-terminal region from another tau
molecule to form dimers [22]. Tau was reported to associ-
ate with the SH3 domain of fyn and src via its proline-rich
domain [23]. Here we show another function of proline-
rich domain. As shown in the results above, PRD binds to
actin with a lower affinity than native tau (Table 2). The
value of Kapp for the complete protein is much lower than
that for either tauPRD or tauMTBD. This suggests again
that both PRD and MTBD are involved in interactions
with actin.
To investigate whether tau or its mutants binds with actin
under physiological ionic strength, as suggested by Roger
and colleagues [24], we observed the interaction of tau
with actin at different concentrations of NaCl. Our results
showed that the interaction between tau and actin
decreased significantly with increasing ionic strength.
However, high ionic strength could not eliminate the
interaction completely. At physiological ionic strength, a
relatively weak interaction was still observed using high
speed co-sedimentation and electron microscopy. We
consider high-speed co-sedimentation and electron
microscopy are more sensitive and accurate methods than
low-speed co-sedimentation. Our results indicate that
interactions between F-actin and tau, tauPRD and
tauMTBD persist at physiological ionic strength.
Tau and MAP2c are two major microtubule binding pro-
teins that are considered to be potential cross-linkers
between microtubules and actin microfilaments. How-
ever, the interaction of MAP2c with actin may be different
in nature. Konati and colleagues found that tau and
MAP2c have different behaviour when studying their
effect on actin filament viscosity [11]. Compared with
MAP2c, the binding of tau to F-actin was relatively weak
at physiological ionic strength [22]. According to
Yamauchi and co-workers [8], phosphatidyl-inositol com-
pletely disrupts MAP2c-induced bundles. However, tau-
induced actin bundles are unaffected by phosphatidyl-
inositol. These reports indicate that tau and MAP2c
behave differently in their interactions with cytoskeletal
components.
Tang and coworkers have proposed the polyelectrolyte
theory for F-actin bundling similar to DNA condensation
[25]. The general behaviour is dictated by the polyelectro-
lyte nature of F-actin, which causes a class of nonspecific
binding by ligands that carry several net positive charges
including divalent metal ions and basic polypeptides.
Such bundling is induced by electrostatic force, and usu-
ally does not require a specific binding site. Tau is a posi-
tively charged protein, with a PI of 9.39 (predicted with
Lasergene). Moraga and co-workers proposed that electro-
static forces are involved in the interaction between actin
and a tau fragment containing a repetitive sequence from
the MTBD domain, because selective carbamoylation
resulted in a complete loss of the peptide induction of
actin bundles [9]. We have shown that the interaction of
tau with F-actin is influenced strongly by ionic strength.
These reports provide evidence that tau may act like poly-
cations to induce F-actin to form bundles. The charge dis-
tribution in tau is depicted in Additional file 5 which
shows that MTBD and PRD are both highly positively
charged, while the N-terminal and C-terminal regions are
neutral or negatively charged according to Wang and cow-
orkers [26]. We hypothesize that electrostatic force is the
basis of the interaction between tauPRD and actin. The
relatively weak and nonspecific nature of the electrostatic
forces between tau and F-actin does not necessarily mean
that the interaction is of no relevance in vivo. Filament
concentration could be higher than we can achieve in
vitro. Besides, several reports have confirmed the physio-
logical importance of this interaction [4,13,14].
Conclusion
In this work, using co-sedimentation assays and solid
phase assays we have shown that the proline-rich domain
(PRD) of tau binds with G-actin and F-actin. The PRD
domain induced G-actin to form filamentous actin and
promoted F-actin to form bundles as observed under both
atomic force microscopy and electron microscopy. The
promotion of actin bundles in the presence of PRD was
also observed in the presence of NaCl under physiological
conditions. According to the results presented here and
other reports in the literature on MTBD associations with
actin, it is suggested that both PRD and MTBD are
involved in the association of tau with actin.
Methods
Construction of mutants
Constructs of tau mutants (tauN, tauPRD, tauMTBD,
tauC, tauΔMTBD and tauΔPRD&MTBD) were prepared by
PCR or megaprimer PCR amplification [27] using human
tau23 clones as templates. Primers used are listed in Addi-
tional file 1. They were then subcloned into the prokaryo-
tic expression vector pET-28a(+) (Novagen, Germany) as
NcoI and XhoI fragments. These five mutants each con-
tained a His-tag at the C-terminus. The clones were trans-
formed into E. coli BL21 (DE3) cells after their nucleotide
sequences had been confirmed by sequencing.
Expression and purification of tau and its mutants
The tau mutants with His-tags were purified with Ni-NTA
resin columns (QIAGEN, Holland) according to the man-
ufacturer's instructions except that cell lysates were boiled
for 5 min and centrifuged before loading on the resin.
Protein samples were concentrated and then purified fur-
ther with HiTrap desalting columns (Amersham Pharma-
cia Biotech, Switzerland). Each purified mutant exhibitedBMC Cell Biology 2009, 10:81 http://www.biomedcentral.com/1471-2121/10/81
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a single protein band on Tris-Tricine gels (Additional file
6-a, b). Low molecular weight protein markers (SIBAS,
Shanghai, China), mixed with aprotinin (MW 6,500),
were used as molecular markers.
The shortest isoform of human tau (tau23) was purified
with Q-Sepharose and SP-Sepharose chromatography
(Amersham Pharmacia Biotech, Switzerland) as described
by Goedert and Jakes [28]. Protein concentrations were
measured with BCA protein assay kits (Pierce, USA).
Western blotting of tau or its mutants
Tau mutants were run on Tris-Tricine gels. The bands on
the gels were verified by staining with monoclonal anti-
His antibodies (Novagen, Germany) (Additional file 1-b).
Tau was run on a 12% SDS-PAGE (Additional file 6-a) and
verified by staining with tau-13 antibodies (Santa Cruz,
USA). All proteins and mutant peptides employed in this
work showed single bands on SDS-PAGE gels or Western
blots (Additional file 1).
Actin preparation
Rabbit skeletal muscle global alpha actin was purified as
described by Spudich and Watt [29]. To improve purity,
actin was assembled in a buffer containing a low ATP con-
centration (0.2 mM) during purification. Human platelet
G-actin (a mixture of 85% beta and 15% gamma iso-
forms) was obtained from Cytoskeleton Inc. and was
resuspended in buffer A (2 mM Tris-HCl pH 8.0, 0.2 mM
ATP, 0.5 mM beta-mercaptoethanol, 0.2 mM CaCl2, and
0.005% NaN3). G-actin proteins were stored at -70°C
after freezing in small volumes in liquid nitrogen. These
samples were thawed rapidly with gentle agitation under
running water at room temperature [30]. Both skeletal
muscle and platelet G-actin showed single bands on SDS-
PAGE gels (Figure 2 and Additional file 6). To obtain F-
actin, G-actin was polymerized in a buffer containing 100
mM KCl, 2 mM MgCl2 and 0.2 mM ATP at 25°C for about
90 min followed by centrifugation (80,000 g, 4°C, and 3
h). The pellet was resuspended in buffer F (100 mM KCl,
1 mM MgCl2, 0.1 mM CaCl2, 0.2 mM ATP, 1 mM Tris-
HCl, pH 8.0, 1 mM NaN3).
Solid phase assays
Experimental conditions were as described by Farias and
co-workers [5] with some modifications. The protein
(skeletal muscle G-actin, platelet G-actin, skeletal muscle
F-actin or platelet F-actin, 5 μg/ml, 50 μl, in 20 mM Tris
pH 8.0 buffer) was coated on 96-well microtiter plates
(Costar, USA), and incubated at 37°C for 2 h to allow
adhesion to the polystyrene surface. After washing three
times with PBST (PBS containing 0.2% Tween 20), the
sites were saturated by incubation with 200 μl of blocking
agent (PBS containing 5% non-fat milk) at 37°C for 30
min. Wells were then washed with binding buffer (50 mM
Hepes containing 0.5 mM EGTA and 0.5 mM MgCl2, pH
7.5) and 50 μl of different concentrations of tau or its
mutants were added. After incubation at 37°C for 45 min,
wells were washed with PBST. Primary antibodies (tau-13,
Santa Cruz, USA) for tau, and an anti-His-Tag monoclonal
antibody (Novagen) for tau mutants were added and
incubated at 37°C for 40 min. Plates were washed with
PBST before the addition of the second antibody (1:1,000
dilution, 100 μl) labelled with horseradish peroxidase
(HRP), and incubated at 37°C for 30 min. After the wells
were washed with PBST, binding of actin with tau was
detected using 100 μl of TMB buffer (6 μg/ml TMB,
0.045% H2O2, 0.1 M PB, pH 6.0) for 10 min, and the reac-
tion was terminated with 50 μl of 2 M H2SO4. The binding
of tau with actin was recorded by measuring the net
change in absorbance at 450 nm by using an automatic
solid phase assay plate reader (Thermo, USA). Correas
and co-workers[7] did not add excess ATP to the reaction
in their study of the interaction of G-actin with tau. Simi-
larly, Roger and coworkers [24] did not use excess ATP
either in studying the bundling of tau with F-actin. Fur-
thermore, Sattilaro and colleagues [31] have reported that
formation of MAP-2-actin bundles is inhibited by milli-
molar concentrations of ATP. Thus, in this work, excess
ATP was not used in the reaction of tau with G-actin or F-
actin.
Co-sedimentation assays
Tau or its mutants was incubated with G-actin or F-actin
(from skeletal muscle or platelet) in binding buffer in the
presence or absence of NaCl (50 - 500 mM) at 37°C for
40 min, and then centrifuged at either 25,000 g for 30 min
or 100,000 g for 1 h at 4°C. The pellet was resuspended
and then boiled for 5 min, followed by electrophoresis on
SDS-PAGE gels.
Atomic force microscopy (AFM) analysis
G-actin, tau and its mutants were incubated in binding
buffer at 37°C for 40 min, and G-actin alone and tau
alone were used as controls. Samples were diluted 2 - 20
times with 20 mM Tris-HCl (pH 8.0). A 10 μl drop of the
protein sample was deposited on freshly cleaved mica,
allowed to stand for 5 min in air, and then washed with
three 200 μl aliquots of buffer solution before drying for
4 min in a stream of nitrogen. Tapping mode AFM was
performed using a Nanoscope IIIa Multimode-AFM
(Veeco Instruments, USA) under ambient conditions. Sil-
icon tips (TESP, Switzerland) with a resonance frequency
of about 250 kHz were used at a scan rate of 1-2 Hz. Once
the tip was engaged, the set point value was adjusted to
minimize the force exerted on the sample while maintain-
ing the sharpness of the image.
Electron microscopy
Tau (or its mutants) and F-actin were incubated in bind-
ing buffer in the presence or absence of NaCl (50 - 500
mM) at 37°C for 40 min. To observe the interaction of F-BMC Cell Biology 2009, 10:81 http://www.biomedcentral.com/1471-2121/10/81
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actin with tau or its mutants, F-actin alone was used as a
control under the same conditions. Samples were placed
on 300-mesh carbon-coated copper grids for 1 min,
washed with H2O and negatively stained with 1% uranyl
acetate for 1 min. The specimens were examined with a
Tecnai 20 electron microscope (Philips, Holland).
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